Fluocinolone acetonide 0.19-mg implant for the treatment of noninfectious uveitis with involvement of the posterior segment: a real-world study

PURPOSE: To evaluate the effectiveness of 0.19-mg fluocinolone acetonide implant (FAi) for preventing inflammatory relapses in noninfectious uveitis with posterior segment involvement in standard clinical practice. Further, to assess the value of remission induction therapy with intraocular and peri...

Descripción completa

Detalles Bibliográficos
Autores principales: Buhl, Lara, Thurau, Stephan, Kern, Christoph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Inflammatory Disorders
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10050064/
https://www.ncbi.nlm.nih.gov/pubmed/36399176
http://dx.doi.org/10.1007/s00417-022-05893-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10050064/
https://www.ncbi.nlm.nih.gov/pubmed/36399176
http://dx.doi.org/10.1007/s00417-022-05893-2

Ejemplares similares